ストックスクリーナーアプリを入手
0.39
2.38%
-0.0095
アフターアワーズ：
.40
0.01
+2.56%
Soligenix Inc (SNGX) 最新ニュース
Soligenix Inc (SNGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Soligenix Inc (SNGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Soligenix Inc (SNGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month On Ebola Vaccine Optimism - Stocktwits
SNGX Stock Price, Quote & Chart - ChartMill
SNGX News | SOLIGENIX INC (NASDAQ:SNGX) - ChartMill
Soligenix Inc (SNGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Soligenix Inc (SNGX) Institutional Confidence - TradingKey
Soligenix Inc (SNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Soligenix Inc (SNGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Soligenix Inc (SNGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Soligenix Inc (SNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Soligenix Q1 2026 Earnings: Narrower-Than-Expected Loss as EPS Beats EstimatesRevenue Breakdown Analysis - newsline.com
Soligenix (SNGX) Hovers Near Key Support After Modest DeclineBearish Pattern Stocks - newsline.com
Soligenix Halts HyBryte Program, Refocuses Pipeline Strategy - TipRanks
Soligenix's Richard C. Straube ceases Consulting CMO role; duties moved to Christopher Pullion - TradingView
Soligenix (NASDAQ: SNGX) faces Nasdaq bid-price risk and ends HyBryte program - Stock Titan
SNGX Q1 2026 Earnings: EPS Beat Amid No Revenue, Stock DeclinesGross Profit Margin - newsline.com
Soligenix (SNGX) Bounces From Support: Biotech Stock Rises 3.5% to $0.44IV Contraction - newsline.com
Soligenix Stock Short Interest Rises to 43.99% - Quiver Quantitative
SNGX Q1 2026 Earnings: Narrower Loss Than Anticipated as Biotech Advances PipelineManagement Guidance Update - newsline.com
Soligenix Announces Recent Accomplishments And Third Quarter 202 - GuruFocus
Soligenix (SNGX) Pursues Vaccine Development for Bundibugyo Viru - GuruFocus
Soligenix (SNGX) stock soars 72% on ThermoVax platform promise amid Ebola outbreak caused by Bundibugyo virus - MSN
Soligenix applies for CEPI funding to develop thermostable vaccine for Bundibugyo Ebola virus. - Pluang
Soligenix (SNGX) Pursues Vaccine Development for Bundibugyo Virus - GuruFocus
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine - Barchart.com
Soligenix (SNGX) Hovers Near Support With Slight DeclineRegression Channel - newsline.com
Soligenix, Inc. Files SEC Form 8-K for May 28, 2026 – Company Information and Legal Exhibits - Minichart
Soligenix Expands At-The-Market Equity Financing Capacity - TipRanks
Soligenixincreases maximum offering under sales agreement by $2.96 million - marketscreener.com
Soligenix raises at‑market share capacity by $2.956M under sales agreement - TradingView
Soligenix (NASDAQ: SNGX) raises at-the-market stock capacity by $2.96M - Stock Titan
Soligenix (NASDAQ: SNGX) raises ATM ceiling to $2.96M under Sales Agreement - Stock Titan
Top Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX - RTTNews
Soligenix Company Profile & Introduction - Moomoo
Soligenix more than doubles as traders react to Ebola-outbreak vaccine-platform update - Quiver Quantitative
$AIM ImmunoTech (AIM.US)$ easiest money i ever made $Soligenix (SNGX.US)$ you 2 booboo - Moomoo
Soligenix (SNGX) Stock Soars 110% as Ebola Outbreak Puts Vaccine Hopes on the Table - MEXC
SNGX Stock Pops On Heavy Volume As Traders Hunt Volatility - StocksToTrade
Soligenix Stock Nearly Doubles Before the Bell as Ebola Vaccine Hopes Put Tiny Biotech Back in Play - TechStock²
$Soligenix (SNGX.US)$ - Moomoo
Top Premarket Gainers - Moomoo
SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month – Ebola Vaccine Optimism Fuels Retail Frenzy - Yahoo Finance
Trending Stocks Today | Soligenix Soars 133.91% Pre-Market - Moomoo
$Soligenix (SNGX.US)$ checkmate [Share Link: Join us in the TradersLink chat.] - Moomoo
Soligenix (SNGX) Stock Soars 72% On ThermoVax Platform Promise Amid Ebola Outbreak Caused By Bundibugyo V - Benzinga
Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo - Lelezard
Soligenix (SNGX) Stock Soars 72% On ThermoVax Platform Promise Amid Ebola Outbreak Caused By Bundibugyo Virus - Sahm
$Soligenix (SNGX.US)$ thank - Moomoo
Soligenix (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss Beats Estimates, Stock SlipsTop Trending Breakouts - Newser
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Soligenix (SNGX) Down -5.08% — Is the Sell-Off Overdone? 2026-05-21Retail Trader Picks - Newser
Soligenix (SNGX) price target decreased by 60.00% to 6.12 - MSN
Soligenix (SNGX) Crushes Q4 2025 Estimates — EPS $-0.28 Tops ViewsIntrinsic Value - Newser
TradingKey - TradingKey
Soligenix (NASDAQ: SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting - USA Today
0.57%
1.15%
大文字化:
|
ボリューム (24 時間):